<DOC>
	<DOCNO>NCT01498120</DOCNO>
	<brief_summary>This Phase 2 , multicenter , open-label , single-arm , optimal dose , long-term follow-up study monotherapy administration rotigotine transdermal patch adolescent Restless Legs Syndrome ( RLS ) . This study assess long-term safety tolerability Rotigotine treatment adolescent RLS .</brief_summary>
	<brief_title>Long-Term Follow-Up Study Safety , Efficacy Tolerability Rotigotine Adolescents With Restless Legs Syndrome</brief_title>
	<detailed_description>Study design change amendment prepared accordingly .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Tolerated first dose level Rotigotine previous study adolescent Restless Legs Syndrome ( RLS ) , without meet withdrawal criterion Is expect benefit participation , opinion investigator Subject/legal representative consider reliable capable adhere protocol , visit schedule , study patch application/removal , accord judgment investigator Previously participate study Is experience ongoing serious adverse event ( SAE ) assess related Rotigotine investigator sponsor Pregnant nursing female childbearing potential surgically sterile consistently use 2 combine medically acceptable method birth control ( include least 1 barrier method ) , unless sexually active Any medical psychiatric condition , opinion investigator , jeopardize would compromise subject 's ability participate Active suicidal ideation indicate positive response ( `` Yes '' ) either Question 4 Question 5 `` Since Last Visit '' version Columbia Suicide Severity Rating Scale ( CSSRS ) final evaluation visit previous Rotigotine study</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>Restless Legs Syndrome</keyword>
	<keyword>RLS</keyword>
	<keyword>Long-term</keyword>
	<keyword>Adolescents</keyword>
</DOC>